JIANGSU KANION PHARMACEUTICAL CO LD revenue breakdown overview

JIANGSU KANION PHARMACEUTICAL CO LD revenue for the last year amounted to 4.87 B CNY, the most of which — 2.17 B CNY — came from its highest performing source at the moment, Injection, the year earlier bringing 1.45 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought JIANGSU KANION PHARMACEUTICAL CO LD 4.87 B CNY, and the year before that — 4.35 B CNY.